1.
Metal ions released from fixed orthodontic appliance affect hair mineral content.
Mikulewicz, M, Wołowiec, P, Loster, B, Chojnacka, K
Biological trace element research. 2015;(1-2):11-8
-
-
Free full text
-
Abstract
The objective was to evaluate metal ion accumulation in hair of patients undergoing orthodontic treatment with fixed appliances in time. The patients (N = 47) participated in a questionnaire survey. Hair sampling was performed at the beginning and in the 4th, 8th, and 12th month of the treatment. The content of metals (Cr, Ni, Fe) in hair was analyzed by ICP-OES equipped with USN nebulizer. The peak release of Cr and Fe occurred after 4 months of the treatment, and the peak release of Ni gradually increased throughout the whole year of the therapy. During 1 year treatment, an average accumulation of metals in hair tissue was 7.42 ± 14.19 μg of Ni, 8.94 ± 13.1 μg of Cr, and 131 ± 279 μg of Fe. The mean content of Cr was higher than the 90th percentile value for this element. The upper limit of literature reference ranges for Cr, Ni, and Fe in hair was not exceeded. The value of exposure (kinetics and dose) of orthodontic patients to metal ions released from orthodontic appliances can be assessed by hair mineral analysis. The content of Cr was statistically significantly higher during the treatment than before the beginning of therapy.
2.
[Biomarker indicators of chemoprevention among subjects occupationally exposed to metals].
Major, J, Jakab, M, Biró, A, Klupp, T, Magyar, B, Gál, K, Oláh, G, Fodor, Z, Tompa, A
Magyar onkologia. 2004;(2):125-9
Abstract
Chemoprevention with chelating agent Humetta for three months was performed, due to anaemia and other haematologic disorders, immunotoxicological alterations and/or increased chromosome aberration rate among galvanisers and goldsmiths occupationally exposed to precious and heavy metals. Twenty-two of altogether 47 subjects took part voluntarily in the chemoprevention, and the rest of the subjects served as untreated controls. Complex clinical laboratory testing including detailed anamneses; genotoxicological and immunotoxicological monitoring were performed before and after administration of chemopreventive agent. After chemoprevention a significant improvement was observed in anaemia and serum glucose levels, while a less marked improvement was found in serum cholesterol levels and liver functions. Altered chromosome aberration and apoptotic cell fraction also tended to normalise after treatment. Immunological parameters were not affected by the treatment. The obtained results may suggest that chemoprevention with chelating agents as Humetta can help in the prevention of harmful effects of occupational exposures to metals.